Lungpacer News & Media
Stay up to date with the latest breakthroughs,
research, and company milestones
Lungpacer Press Release
Lungpacer Medical Announces First Enrollments in STARI Trial of Next-Generation Neurostimulation Therapy
STARI will investigate continual diaphragm neurostimulation to improve lung, diaphragm, cardiac and brain function at the earliest stages of mechanical ventilation
Read The Article
Lungpacer Press Release
Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule
Read The Article
Lungpacer Featured In
After Tragedy, an Entrepreneur’s Triumph
Brian Gormley of the Wall Street Journal publishes article on Lungpacer’s 15-year journey from a deeply personal mission
Read The Article
Sort by:
Harmony, Lungpacer, Verrica and Arbutus make C-suite hires
April 1, 2025
News
Lungpacer Medical Names Kevin Kearney as Chief Commercial Officer
March 27, 2025
News
To Prep for First Product Launch, Exton’s Lungpacer Medical Doubles Workforce
March 27, 2025
News
Lungpacer Medical names Kevin Kearney as CCO
March 25, 2025
News
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
March 24, 2025
Press Release
Lungpacer wins FDA IDE for AeroNova system
March 10, 2025
News
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
March 10, 2025
Press Release
Lungpacer Medical Shares Promising Results from STIMULUS Trial
February 20, 2025
News
Data backs Lungpacer Medical’s diaphragm neurostim
February 20, 2025
News
